- Home
- SBFM vs MULN Comparison
SBFM vs MULN Comparison
Compare SBFM & MULN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- MULN
- Stock Information
- Founded
- SBFM 2006
- MULN 2014
- Country
- SBFM United States
- MULN United States
- Employees
- SBFM N/A
- MULN N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- MULN Auto Manufacturing
- Sector
- SBFM Health Care
- MULN Consumer Discretionary
- Exchange
- SBFM Nasdaq
- MULN Nasdaq
- Market Cap
- SBFM 3.7M
- MULN 4.1M
- IPO Year
- SBFM N/A
- MULN N/A
- Fundamental
- Price
- SBFM $3.00
- MULN $2.36
- Analyst Decision
- SBFM
- MULN
- Analyst Count
- SBFM 0
- MULN 0
- Target Price
- SBFM N/A
- MULN N/A
- AVG Volume (30 Days)
- SBFM 153.8K
- MULN 2.4M
- Earning Date
- SBFM 11-11-2024
- MULN 08-12-2024
- Dividend Yield
- SBFM N/A
- MULN N/A
- EPS Growth
- SBFM N/A
- MULN N/A
- EPS
- SBFM N/A
- MULN N/A
- Revenue
- SBFM $30,481,982.00
- MULN $156,570.00
- Revenue This Year
- SBFM $86.70
- MULN N/A
- Revenue Next Year
- SBFM $126.76
- MULN N/A
- P/E Ratio
- SBFM N/A
- MULN N/A
- Revenue Growth
- SBFM 109.82
- MULN N/A
- 52 Week Low
- SBFM $2.42
- MULN $2.10
- 52 Week High
- SBFM $660.00
- MULN $3,600.00
- Technical
- Relative Strength Index (RSI)
- SBFM 46.45
- MULN 20.09
- Support Level
- SBFM $2.85
- MULN $2.10
- Resistance Level
- SBFM $3.05
- MULN $2.70
- Average True Range (ATR)
- SBFM 0.15
- MULN 0.45
- MACD
- SBFM 0.02
- MULN 2.03
- Stochastic Oscillator
- SBFM 43.59
- MULN 13.90
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
About MULN Mullen Automotive Inc.
Mullen Automotive Inc is engaged in manufacturing electric vehicles and energy solutions. The company strives to make electric vehicles more accessible by building an end-to-end ecosystem that takes care of all aspects of electric vehicle ownership. The Company owns and partners with several synergistic businesses, all working towards the same goal of creating clean and scalable electric vehicles and energy solutions. The company has two segments Bollinger and Mullen/ELMS, which generates revenue.